Cleared Traditional

Oximeter (Model: JZK-301,JZK-303,JZK-305,JZK-307) (K213984) - FDA 510(k) Clearance

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K213984 · Shenzhen Zhengkang Technology Co., Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2022
Decision
361d
Days
Class 2
Risk

K213984 is an FDA 510(k) clearance for the Oximeter (Model: JZK-301,JZK-303,JZK-305,JZK-307). Classified as Oximeter (product code DQA), Class II - Special Controls.

Submitted by Shenzhen Zhengkang Technology Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on December 16, 2022 after a review of 361 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Shenzhen Zhengkang Technology Co., Ltd. devices

Submission Details

510(k) Number K213984 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 2021
Decision Date December 16, 2022
Days to Decision 361 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
221d slower than avg
Panel avg: 140d · This submission: 361d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQA Oximeter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

Feiying Drug & Medical Consulting Technical Service Group
Becky Chen

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DQA Oximeter

All 181
Devices cleared under the same product code (DQA) and FDA review panel - the closest regulatory comparables to K213984.
Fingertip Pulse Oximeter
K213430 · Shenzhen Witleaf Medical Electronics Co., Ltd. · Dec 2022
Biobeat Platform-2 and BB-613WP Patch
K222010 · Biobeat Technologies , Ltd. · Dec 2022
Pulse Oximeter (UC-200, UC-201, UC-202, UC-203, UC-204, UC-100, UC-101, UC-102, UC-103, UC-104)
K222213 · Unimed Medical Supplies, Inc. · Dec 2022
Empatica Health Monitoring Platform
K221282 · Empatica S.R.L. · Nov 2022
Polso Watch
K220351 · Chronisense Medical, Ltd. · Nov 2022
Oxyfit Pulse Oximeter
K203812 · Shenzhen Viatom Technology Co., Ltd. · Nov 2022